Table 1.
Patient characteristics (n = 30).
| Variables | Total (%) |
|---|---|
| Age | |
| Mean | 66 |
| range | 40–87 |
| Sex | |
| Male | 27 (90) |
| Female | 3 (10) |
| Recurrent site | |
| Larynx | 18 (60) |
| Oropharynx | 8 (27) |
| hypopharynx | 4 (13) |
| Treatment before recurrence | |
| Chemo-radiotherapy | 16 (53) |
| Radiotherapy | 14 (47) |
| Radiation dosage before recurrence | |
| Median | 66.0 Gy |
| Range | 60–70.2 Gy |
| p16 status | |
| Positive | 6 (20) |
| Negative | 24 (80) |
| Local recurrence | |
| Early | 22 (73) |
| Advance | 8 (27) |
| Regional recurrence | |
| Yes | 2 (7) |
| No | 28 (93) |
| Treatment at recurrence | |
| Surgery | 22 (73) |
| Chemotherapy | 3 (10) |
| Cetuximab + chemotherapy | 3 (10) |
| Nivolumab | 2 (7) |
| Follow up (months) form recurrence | |
| Median | 63.1 |
| Range | 15.3–146.2 |